Summary
3M Company's (MMM) second-quarter 2019 report shows a notable decrease in net sales and operating income compared to the prior year, reflecting challenging macroeconomic conditions and strategic inventory adjustments. Net sales declined by 2.6% year-over-year to $8.17 billion, while operating income dropped significantly by 29.1% to $1.7 billion. This downturn was broad-based across key segments like Safety and Industrial and Transportation and Electronics, impacted by slowing demand in automotive, electronics, and industrial markets, particularly in Asia Pacific and the U.S. The company also incurred a substantial pre-tax charge of $148 million for restructuring actions impacting approximately 2,000 positions globally. The Health Care segment demonstrated resilience with a 5.8% sales increase. Investors should note the company's ongoing efforts to streamline operations and its cautious outlook given the market headwinds.
Financial Highlights
54 data points| Revenue | $8.17B |
| Cost of Revenue | $4.31B |
| Gross Profit | $3.86B |
| SG&A Expenses | $1.69B |
| Operating Expenses | $6.47B |
| Operating Income | $1.70B |
| Interest Expense | $111.00M |
| Net Income | $1.13B |
| EPS (Basic) | $1.95 |
| EPS (Diluted) | $1.92 |
| Shares Outstanding (Basic) | 577.70M |
| Shares Outstanding (Diluted) | 586.10M |
Key Highlights
- 1Net sales for the quarter decreased by 2.6% to $8.17 billion compared to the prior year's $8.39 billion.
- 2Operating income saw a significant decline of 29.1% to $1.70 billion from $2.40 billion in the same period last year.
- 3Earnings per diluted share (EPS) decreased by 37.5% to $1.92, compared to $3.07 in the prior year's quarter.
- 4The Safety and Industrial segment experienced a substantial 9.0% sales decline, impacting overall company performance.
- 5The Health Care segment showed growth, with sales increasing by 5.8% to $1.83 billion.
- 63M incurred $148 million in pre-tax restructuring charges, affecting approximately 2,000 positions worldwide.
- 7The company repurchased $1.1 billion of its own stock in the first six months of 2019, continuing its capital return strategy.